Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Fixed Capital/Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Fixed Capital/Sales(x) 0.450.450.440.470.44

What is the latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 0.45 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.45
Mar20230.45
Mar20220.44
Mar20170.47
Mar20160.44

How is Fixed Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.45
0.00
Mar2023 0.45
2.27
Mar2022 0.44
-6.38
Mar2017 0.47
6.82
Mar2016 0.44 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Fixed Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,545.4 Cr 5.6% 1.9% 13.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,588.0 Cr -7.3% 1.1% 15.2% Stock Analytics
DIVIS LABORATORIES ₹157,711.0 Cr -3.5% 12.9% 53.4% Stock Analytics
CIPLA ₹122,115.0 Cr 0.1% 9.2% 6.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,589.0 Cr -1% 0.2% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,746.6 Cr 3.1% 9.8% -7.6% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

5.6%

1.9%

13.2%

SENSEX

2%

9.4%

11.6%


You may also like the below Video Courses